Dr. Sandeep Goyle - Top Medical Oncologist in Mumbai - Safartibbi

Dr. Sandeep Goyle

Head, Medical Oncology
17+ years of experience
Kokilaben Dhirubhai Ambani Hospital, Mumbai

Opening Hours

Monday – Friday 8.00 – 7:00 pm
Saturday 9.00 – 8.00 pm
Sunday 10.00 – 9.00 pm

About Doctor

  • Dr. Sandeep Goyle is a medical oncologist with 17+ years of experience.
  • He is a consultant Medical Oncologist associated with Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai  since Nov 2008.
  • He initiated the chemotherapy day care facility at the hospital in November 2008.
  • Dr. Goyle has trained in Medical Oncology in the best centers in the United Kingdom.
  • He pursued Oncology training from Christie hospital-Manchester UK and St James hospital, Leeds, UK
  • Under his credit, there are both national and international publications accredited in indexed journals.
Qualification & Training
  • MBBS, Seth GS Medical College and K.E.M Hospital, Mumbai.
  • MD, TN Medical College and B.Y.L. Nair Hospital, Mumbai.
  • DNB, National Board of Examinations.
  • MSc from University of Manchester, UK 
  • CCST from Joint College of Higher Medical Training, UK 
  • MRCP (UK) from Royal College of Physicians of London
Areas of Clinical interests

Achievements and Awards:

  • Emerging Star of medicine award – IMA, Mumbai West branch
  • Medical Prize – for MRCP (UK) awarded by Queen Mary’s Hospital, Sidcup, Kent
  • Postgraduate merit scholarship – awarded by University of Mumbai, during M.D.General Medicine course

Member of Associations:

  • Member of Mumbai Oncology Association 
  • Member of Mumbai Haematology group,
  • Member of Indian Society of Medical and Paediatric Oncology 
  • Member of Indian Medical Association,
  • Member of European Society of Medical Oncology,
  • Member of American Society of Clinical Oncology,

List of Treatments

  • Acute Lymphocytic Leukemia – ALL in Adults
  • Adrenal Cancer Treatment
  • Anal Cancer Treatment
  • Bile Duct Cancer Treatment
  • Bladder Cancer Treatment
  • Breast Biopsy
  • Breast Cancer-Surgical
  • Cancer in Children
  • Carcinoma of Unknown Primary (CUP) Treatment
  • Castleman Disease Treatment
  • Cervical Cancer Treatment
  • Chemotherapy
  • Endometrial Cancer Treatment
  • Esophagus Cancer Treatment
  • Ewing Family of Tumors Treatment
  • Eye Cancer Treatment
  • Gallbladder Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hairy Cell Leukemia – HCL
  • Hodgkin Disease Treatment
  • Laryngeal and Hypopharyngeal Cancer Treatment
  • Leukemia in Children
  • Liver Cancer
  • Lung Cancer Treatment
  • Lung Carcinoid Tumor Treatment
  • Malignant Mesothelioma Treatment
  • Nasopharyngeal Cancer Treatment
  • Neuroblastoma
  • Non-Hodgkin Lymphoma (NHL) Treatment
  • Non-Hodgkin Lymphoma In Children
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Oral Cavity and Oropharyngeal Cancer
  • Ovarian Cancer Surgery
  • Pancreatic Cancer
  • Penile Cancer Treatment
  • Prostate Cancer-Surgical
  • Retinoblastoma (RB) Treatment
  • Rhabdomyosarcoma (RMS) Treatment
  • Salivary Gland Cancer
  • Skin Cancer
  • Skin Cancer – Melanoma
  • Skin Lymphoma Treatment
  • Small-cell Carcinoma Treatment